Seaweed extract may hold promise for non-Hodgkin’s lymphoma treatment
March 9, 2010 by admin · Leave a Comment
Contact: Jeremy Moore
jeremy.moore@aacr.org
267-646-0557
American Association for Cancer Research
DEAD SEA, Jordan Seaweed extract may eventually emerge as a lymphoma treatment, according to laboratory research presented at the second AACR Dead Sea International Conference on Advances in Cancer Research: From the Laboratory to the Clinic, held here March 7-10, 2010.
New cancer treatment gives hope to lymphoma and leukemia patients
February 25, 2010 by admin · Leave a Comment
Contact: Steve Yozwiak
syozwiak@tgen.org
602-343-8704
The Translational Genomics Research Institute Read more
Scott & White Healthcare researching treatments for rare cancers
Contact: Katherine Voss
kvoss@swmail.sw.org
254-724-4097
Scott & White Healthcare
Scott & White’s Cancer Research Institute (CRI) has launched two clinical trials targeting cancers that affect both adults and children.
A new target for lymphoma therapy
December 8, 2009 by admin · Leave a Comment
Contact: Rob Graham
Rob.Graham@childrens.harvard.edu
617-919-3110
Children’s Hospital Boston Read more
Clinical Trial For New Cancer Treatment for Non-Hodgkin’s Lymphoma
November 22, 2009 by admin · Leave a Comment
Physician-scientists from Weill Cornell Medical College have discovered a molecular mechanism that may prove to be a powerful target for the treatment of non-Hodgkin’s lymphoma, a type of cancer that affects lymphocytes, or white blood cells. By exploiting this mechanism, researchers have been able to powerfully suppress tumor formation in lab testing and in animal models. Read more
Experimental drug lets B cells live and lymphoma cells die
September 21, 2009 by admin · Leave a Comment
An investigative drug deprived non-Hodgkin lymphoma cells of their ability to survive too long and multiply too fast, according to an early study published recently in the journal Experimental Hematology.
New treatment approach promising for lymphoma patients in the developing world
July 6, 2008 by admin · Leave a Comment
Preliminary results suggest that patients with aggressive non-Hodgkin’s lymphoma in the developing world might benefit from a modified chemotherapy regimen, researchers say.
At the ESMO Conference Lugano (ECLU) organized by the European Society for Medical Oncology, a group headed by Prof. Hamdy Azim from Cairo University reports that giving these patients chemotherapy every 2 weeks, rather than every 3 weeks as usual, improved treatment outcomes.
Crucial Factors in Lymphoma Development and Survival Discovered
June 23, 2008 by admin · Leave a Comment
Researchers at National Jewish Medical and Research Center have discovered an important factor in the development of B-cell lymphomas, one of the fastest growing forms of cancer. The B-cell receptor on the surface of B cells can cooperate with the MYC oncogene to accelerate the development of lymphomas. The research team, led by Yosef Refaeli, PhD, Assistant Professor of Pediatrics at National Jewish Medical and Research Center , also showed that disruption of signals from the B-cell receptor can inhibit growth of the tumors. The research is being published in the June 24 issue of the journal, PLos Biology.
Scientists studying the effects of high-dose vitamin C on non-Hodgkin lymphoma patients
January 3, 2008 by admin · Leave a Comment
Vitamin C’s low toxicity lends high hopes to pioneering study
Scientists at Thomas Jefferson University Hospital and Jeffersons Kimmel Cancer Center have received approval for a first-of-its kind study on the effect high dose vitamin C has on non-Hodgkin lymphoma patients. Researchers from the Jefferson-Myrna Brind Center of Integrative Medicine and Kimmel Cancer Center in conjunction with the National Institutes of Health will study whether high doses of vitamin C can slow the progression of the deadly disease.
What’s in store? Hopes and dreams and so much more
July 31, 2007 by admin · Leave a Comment
Filed under: Non-Hodgkins Lymphoma, Hodgkin’s Lymphoma, Products
